Kapoor P - Search Results

1

Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents.

Majithia N, Rajkumar SV, Lacy MQ, Buadi FK, Dispenzieri A, Gertz MA, Hayman SR, Dingli D, Kapoor P, Hwa L, Lust JA, Russell SJ, Go RS, Kyle RA, Kumar SK. Majithia N, et al. Among authors: kapoor p. Leukemia. 2016 Nov;30(11):2208-2213. doi: 10.1038/leu.2016.147. Epub 2016 May 23. Leukemia. 2016. PMID: 27211270 Free PMC article.

2

Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis.

Kapoor P, Rajkumar SV, Dispenzieri A, Gertz MA, Lacy MQ, Dingli D, Mikhael JR, Roy V, Kyle RA, Greipp PR, Kumar S, Mandrekar SJ. Kapoor P, et al. Leukemia. 2011 Apr;25(4):689-96. doi: 10.1038/leu.2010.313. Epub 2011 Jan 14. Leukemia. 2011. PMID: 21233832

3

Long-term outcome with lenalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.

Srivastava G, Rana V, Lacy MQ, Buadi FK, Hayman SR, Dispenzieri A, Gertz MA, Dingli D, Zeldenrust S, Russell S, McCurdy A, Kapoor P, Kyle R, Rajkumar SV, Kumar S. Srivastava G, et al. Among authors: kapoor p. Leukemia. 2013 Oct;27(10):2062-6. doi: 10.1038/leu.2013.143. Epub 2013 May 7. Leukemia. 2013. PMID: 23648667 Free PMC article.

4

Long-term outcome of patients with multiple [corrected] myeloma-related advanced renal failure following auto-SCT.

Glavey SV, Gertz MA, Dispenzieri A, Kumar S, Buadi F, Lacy M, Hayman SR, Kapoor P, Dingli D, McCurdy A, Hogan WJ, Gastineau DA, Leung N. Glavey SV, et al. Among authors: kapoor p. Bone Marrow Transplant. 2013 Nov;48(12):1543-7. doi: 10.1038/bmt.2013.109. Epub 2013 Aug 5. Bone Marrow Transplant. 2013. PMID: 23912663

5

Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients.

Kumar SK, Dispenzieri A, Lacy MQ, Gertz MA, Buadi FK, Pandey S, Kapoor P, Dingli D, Hayman SR, Leung N, Lust J, McCurdy A, Russell SJ, Zeldenrust SR, Kyle RA, Rajkumar SV. Kumar SK, et al. Among authors: kapoor p. Leukemia. 2014 May;28(5):1122-8. doi: 10.1038/leu.2013.313. Epub 2013 Oct 25. Leukemia. 2014. PMID: 24157580 Free PMC article.

6

Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma.

Gonsalves WI, Rajkumar SV, Gupta V, Morice WG, Timm MM, Singh PP, Dispenzieri A, Buadi FK, Lacy MQ, Kapoor P, Gertz MA, Kumar SK. Gonsalves WI, et al. Among authors: kapoor p. Leukemia. 2014 Oct;28(10):2060-5. doi: 10.1038/leu.2014.98. Epub 2014 Mar 12. Leukemia. 2014. PMID: 24618735 Free PMC article.

7

Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma.

Gonsalves WI, Leung N, Rajkumar SV, Dispenzieri A, Lacy MQ, Hayman SR, Buadi FK, Dingli D, Kapoor P, Go RS, Lin Y, Russell SJ, Lust JA, Zeldenrust S, Kyle RA, Gertz MA, Kumar SK. Gonsalves WI, et al. Among authors: kapoor p. Blood Cancer J. 2015 Mar 20;5(3):e296. doi: 10.1038/bcj.2015.20. Blood Cancer J. 2015. PMID: 25794132 Free PMC article.

8

Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy.

Alhaj Moustafa M, Rajkumar SV, Dispenzieri A, Gertz MA, Lacy MQ, Buadi FK, Hwa YL, Dingli D, Kapoor P, Hayman SR, Lust JA, Kyle RA, Kumar SK. Alhaj Moustafa M, et al. Among authors: kapoor p. Leukemia. 2015 Oct;29(10):2033-8. doi: 10.1038/leu.2015.118. Epub 2015 May 12. Leukemia. 2015. PMID: 25962523 Free PMC article.

9

Phase 2 trial of ixazomib in patients with relapsed multiple myeloma not refractory to bortezomib.

Kumar SK, LaPlant B, Roy V, Reeder CB, Lacy MQ, Gertz MA, Laumann K, Thompson MA, Witzig TE, Buadi FK, Rivera CE, Mikhael JR, Bergsagel PL, Kapoor P, Hwa L, Fonseca R, Stewart AK, Chanan-Khan A, Rajkumar SV, Dispenzieri A. Kumar SK, et al. Among authors: kapoor p. Blood Cancer J. 2015 Aug 14;5(8):e338. doi: 10.1038/bcj.2015.60. Blood Cancer J. 2015. PMID: 26275080 Free PMC article. Clinical Trial.

10

Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma.

Kaufman GP, Gertz MA, Dispenzieri A, Lacy MQ, Buadi FK, Dingli D, Hayman SR, Kapoor P, Lust JA, Russell S, Go RS, Hwa YL, Kyle RA, Rajkumar SV, Kumar SK. Kaufman GP, et al. Among authors: kapoor p. Leukemia. 2016 Mar;30(3):633-9. doi: 10.1038/leu.2015.287. Epub 2015 Oct 21. Leukemia. 2016. PMID: 26487275

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

856 results

Search Page

Filters